Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1841 1
1851 1
1883 1
1884 1
1886 1
1887 1
1890 1
1893 1
1899 1
1901 1
1910 1
1912 1
1913 2
1914 1
1916 1
1918 2
1921 1
1928 1
1932 1
1933 1
1934 1
1945 3
1946 11
1947 8
1948 8
1949 9
1950 8
1951 16
1952 8
1953 10
1954 5
1955 8
1956 8
1957 7
1958 5
1959 6
1960 2
1961 10
1962 11
1963 16
1964 10
1965 14
1966 15
1967 5
1968 20
1969 31
1970 26
1971 37
1972 34
1973 31
1974 41
1975 33
1976 29
1977 44
1978 31
1979 35
1980 38
1981 22
1982 43
1983 43
1984 52
1985 40
1986 43
1987 56
1988 43
1989 51
1990 50
1991 45
1992 47
1993 36
1994 49
1995 47
1996 46
1997 47
1998 51
1999 30
2000 49
2001 45
2002 43
2003 32
2004 49
2005 31
2006 37
2007 44
2008 105
2009 112
2010 77
2011 97
2012 83
2013 72
2014 91
2015 92
2016 103
2017 88
2018 97
2019 104
2020 125
2021 129
2022 111
2023 104
2024 95
2025 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,341 results

Results by year

Filters applied: . Clear all
Page 1
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG. Donnelly JP, et al. Among authors: thompson gr. Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. doi: 10.1093/cid/ciz1008. Clin Infect Dis. 2020. PMID: 31802125 Free PMC article.
Invasive candidiasis.
Lass-Flörl C, Kanj SS, Govender NP, Thompson GR 3rd, Ostrosky-Zeichner L, Govrins MA. Lass-Flörl C, et al. Among authors: thompson gr 3rd. Nat Rev Dis Primers. 2024 Mar 21;10(1):20. doi: 10.1038/s41572-024-00503-3. Nat Rev Dis Primers. 2024. PMID: 38514673 Review.
Coccidioidomycosis.
Bays DJ, Thompson GR 3rd. Bays DJ, et al. Among authors: thompson gr 3rd. Infect Dis Clin North Am. 2021 Jun;35(2):453-469. doi: 10.1016/j.idc.2021.03.010. Infect Dis Clin North Am. 2021. PMID: 34016286 Review.
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ. Maertens JA, et al. Among authors: thompson gr 3rd. Lancet. 2016 Feb 20;387(10020):760-9. doi: 10.1016/S0140-6736(15)01159-9. Epub 2015 Dec 10. Lancet. 2016. PMID: 26684607 Clinical Trial.
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.
Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, Lass-Flörl C, Ostrosky-Zeichner L, Rautemaa-Richardson R, Revathi G, Santolaya ME, White PL, Alastruey-Izquierdo A, Arendrup MC, Baddley J, Barac A, Ben-Ami R, Brink AJ, Grothe JH, Guinea J, Hagen F, Hochhegger B, Hoenigl M, Husain S, Jabeen K, Jensen HE, Kanj SS, Koehler P, Lehrnbecher T, Lewis RE, Meis JF, Nguyen MH, Pana ZD, Rath PM, Reinhold I, Seidel D, Takazono T, Vinh DC, Zhang SX, Afeltra J, Al-Hatmi AMS, Arastehfar A, Arikan-Akdagli S, Bongomin F, Carlesse F, Chayakulkeeree M, Chai LYA, Chamani-Tabriz L, Chiller T, Chowdhary A, Clancy CJ, Colombo AL, Cortegiani A, Corzo Leon DE, Drgona L, Dudakova A, Farooqi J, Gago S, Ilkit M, Jenks JD, Klimko N, Krause R, Kumar A, Lagrou K, Lionakis MS, Lmimouni BE, Mansour MK, Meletiadis J, Mellinghoff SC, Mer M, Mikulska M, Montravers P, Neoh CF, Ozenci V, Pagano L, Pappas P, Patterson TF, Puerta-Alcalde P, Rahimli L, Rahn S, Roilides E, Rotstein C, Ruegamer T, Sabino R, Salmanton-García J, Schwartz IS, Segal E, Sidharthan N, Singhal T, Sinko J, Soman R, Spec A, Steinmann J, Stemler J, Taj-Aldeen SJ, Talento AF, Thompson GR 3rd, Toebben C, Villanueva-Lozano H, Wahyu… See abstract for full author list ➔ Cornely OA, et al. Among authors: thompson gr 3rd. Lancet Infect Dis. 2025 May;25(5):e280-e293. doi: 10.1016/S1473-3099(24)00749-7. Epub 2025 Feb 13. Lancet Infect Dis. 2025. PMID: 39956121 Free article. Review.
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison T, Pappas PG; ReSTORE trial investigators. Thompson GR 3rd, et al. Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25. Lancet. 2023. PMID: 36442484 Free article. Clinical Trial.
Breakthrough invasive fungal infections: Who is at risk?
Jenks JD, Cornely OA, Chen SC, Thompson GR 3rd, Hoenigl M. Jenks JD, et al. Among authors: thompson gr 3rd. Mycoses. 2020 Oct;63(10):1021-1032. doi: 10.1111/myc.13148. Epub 2020 Sep 4. Mycoses. 2020. PMID: 32744334 Review.
Coccidioidomycosis.
Stockamp NW, Thompson GR 3rd. Stockamp NW, et al. Among authors: thompson gr 3rd. Infect Dis Clin North Am. 2016 Mar;30(1):229-46. doi: 10.1016/j.idc.2015.10.008. Epub 2015 Dec 29. Infect Dis Clin North Am. 2016. PMID: 26739609 Review.
Impact of climate change and natural disasters on fungal infections.
Seidel D, Wurster S, Jenks JD, Sati H, Gangneux JP, Egger M, Alastruey-Izquierdo A, Ford NP, Chowdhary A, Sprute R, Cornely O, Thompson GR 3rd, Hoenigl M, Kontoyiannis DP. Seidel D, et al. Among authors: thompson gr 3rd. Lancet Microbe. 2024 Jun;5(6):e594-e605. doi: 10.1016/S2666-5247(24)00039-9. Epub 2024 Mar 19. Lancet Microbe. 2024. PMID: 38518791 Free article. Review.
Coccidioidomycosis: Recent Updates.
Twarog M, Thompson GR 3rd. Twarog M, et al. Among authors: thompson gr 3rd. Semin Respir Crit Care Med. 2015 Oct;36(5):746-55. doi: 10.1055/s-0035-1562900. Epub 2015 Sep 23. Semin Respir Crit Care Med. 2015. PMID: 26398540 Review.
3,341 results